Search research articles
Contact Us
Filters
Showing results (131-140 of 144) with videos related to
Page
of 15
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Synthesis and biological activities of phenyl piperazine-based peptidomimetic growth hormone secretagogues
K J Barakat, K Cheng, W W Chan, et al.
Influenza and Other Respiratory Viruses
|
September 5, 2013
Infection of swine ex vivo tissues with avian viruses including H7N9 and correlation with glycomic analysis
Renee W Y Chan, Rositsa Karamanska, Sjouke Van Poucke, et al.
Healthcare (Basel, Switzerland)
|
October 13, 2023
Cross-Cultural Adaptation and Psychometric Properties of the Traditional Chinese Version of the Italian Spine Youth Quality of Life (ISYQOL) Questionnaire
Ava Ying Cheng, Pik Kwan Jim, Ning Wai Kwan, et al.
World Journal of Surgery
|
January 25, 2012
Early data from the first population-wide breast cancer-specific registry in Hong Kong
Polly Cheung, W K Hung, Catherine Cheung, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 24, 2021
Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure
T C Lam, K C Tsang, H C Choi, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 15, 2000
Modeling directed design and biological evaluation of quinazolinones as non-peptidic growth hormone secretagogues
Z Ye, Y Gao, R K Bakshi, et al.
Journal of Medicinal Chemistry
|
May 30, 1998
A potent, orally bioavailable benzazepinone growth hormone secretagogue
R J DeVita, R Bochis, A J Frontier, et al.
Clinical Breast Cancer
|
April 24, 2016
The Impact of the Oncotype DX Breast Cancer Assay on Treatment Decisions for Women With Estrogen Receptor-Positive, Node-Negative Breast Carcinoma in Hong Kong
Roland C Y Leung, Thomas C C Yau, Miranda C M Chan, et al.
Breast Cancer Research and Treatment
|
April 9, 2009
A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer
Ava Kwong, L P Wong, H N Wong, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|
December 4, 2025
Expert consensus recommendations on the daily clinical use of pembrolizumab for early triple-negative breast cancer
W Yeo, Y H Y Chan, R C Y Leung, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 144) with videos related to
Sort By:
Page
of 15
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Synthesis and biological activities of phenyl piperazine-based peptidomimetic growth hormone secretagogues
K J Barakat, K Cheng, W W Chan, et al.
Influenza and Other Respiratory Viruses
|
September 5, 2013
Infection of swine ex vivo tissues with avian viruses including H7N9 and correlation with glycomic analysis
Renee W Y Chan, Rositsa Karamanska, Sjouke Van Poucke, et al.
Healthcare (Basel, Switzerland)
|
October 13, 2023
Cross-Cultural Adaptation and Psychometric Properties of the Traditional Chinese Version of the Italian Spine Youth Quality of Life (ISYQOL) Questionnaire
Ava Ying Cheng, Pik Kwan Jim, Ning Wai Kwan, et al.
World Journal of Surgery
|
January 25, 2012
Early data from the first population-wide breast cancer-specific registry in Hong Kong
Polly Cheung, W K Hung, Catherine Cheung, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 24, 2021
Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure
T C Lam, K C Tsang, H C Choi, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 15, 2000
Modeling directed design and biological evaluation of quinazolinones as non-peptidic growth hormone secretagogues
Z Ye, Y Gao, R K Bakshi, et al.
Journal of Medicinal Chemistry
|
May 30, 1998
A potent, orally bioavailable benzazepinone growth hormone secretagogue
R J DeVita, R Bochis, A J Frontier, et al.
Clinical Breast Cancer
|
April 24, 2016
The Impact of the Oncotype DX Breast Cancer Assay on Treatment Decisions for Women With Estrogen Receptor-Positive, Node-Negative Breast Carcinoma in Hong Kong
Roland C Y Leung, Thomas C C Yau, Miranda C M Chan, et al.
Breast Cancer Research and Treatment
|
April 9, 2009
A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer
Ava Kwong, L P Wong, H N Wong, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|
December 4, 2025
Expert consensus recommendations on the daily clinical use of pembrolizumab for early triple-negative breast cancer
W Yeo, Y H Y Chan, R C Y Leung, et al.
Page
of 15